Hanbin Li
Impact in
- Parasitology top 5%
- Parasitic Infections and Diagnostics
-
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
Papers in
- Oncology 9
- HER2/EGFR in Cancer Research 7
-
- Cardiac electrophysiology and arrhythmias 3
- Cardiomyopathy and Myosin Studies 3
- Co-authors
- Gordon R. Finch (5 shared papers)Miodrag Belosevic (4 shared papers)Lyndon L. Gyürék (2 shared papers)Angelica Quartino (5 shared papers)Daniel W. Smith (3 shared papers)Amit Garg (5 shared papers)Russell Wada (3 shared papers)Jin Y. Jin (4 shared papers)
- Journals
- Cancer Chemotherapy and Pharmacology (5 papers)Journal of Environmental Engineering (3 papers)The Journal of Clinical Pharmacology (3 papers)CPT Pharmacometrics & Systems Pharmacology (2 papers)Clinical Pharmacokinetics (2 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Hanbin Li
35 papers receiving 565 citations
Peers
Comparison fields: 5 of 97
- Parasitology 75
- Oncology 124
- Radiology, Nuclear Medicine and Imaging 86
- Health, Toxicology and Mutagenesis 55
- Infectious Diseases 57
Countries citing papers authored by Hanbin Li
This map shows the geographic impact of Hanbin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanbin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanbin Li more than expected).
Fields of papers citing papers by Hanbin Li
This network shows the impact of papers produced by Hanbin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanbin Li. The network helps show where Hanbin Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Hanbin Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 63 | |
| 2 | 2015 | 61 | |
| 3 | 2014 | 53 | |
| 4 | 2015 | 38 | |
| 5 | 2022 | 36 | |
| 6 | 2011 | 33 | |
| 7 | 2001 | 33 | |
| 8 | 2018 | 30 | |
| 9 | 2018 | 27 | |
| 10 | 2019 | 25 | |
| 11 | 2001 | 24 | |
| 12 | 2012 | 23 | |
| 13 | 2017 | 19 | |
| 14 | 1999 | 16 | |
| 15 | 2024 | 15 | |
| 16 | 2001 | 12 | |
| 17 | 2017 | 11 | |
| 18 | 2019 | 10 | |
| 19 | 2013 | 9 | |
| 20 | 2019 | 8 |
About Hanbin Li
Hanbin Li is a scholar working on Oncology, Cardiology and Cardiovascular Medicine, Parasitology, Molecular Biology and Epidemiology, having authored 38 papers that have together received 601 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (7 papers), Parasitic Infections and Diagnostics (5 papers), Cardiac electrophysiology and arrhythmias (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Hepatitis C virus research (3 papers), Cardiomyopathy and Myosin Studies (3 papers), Liver Disease Diagnosis and Treatment (2 papers) and Breast Cancer Treatment Studies (2 papers). The work is most often cited by research in Parasitology (75 citations), Oncology (124 citations), Radiology, Nuclear Medicine and Imaging (86 citations), Health, Toxicology and Mutagenesis (55 citations) and Infectious Diseases (57 citations). Hanbin Li has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Gordon R. Finch, Miodrag Belosevic, Lyndon L. Gyürék, Angelica Quartino, Daniel W. Smith, Amit Garg, Russell Wada, Jin Y. Jin, Jing Li and Jennifer Visich. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Journal of Environmental Engineering, The Journal of Clinical Pharmacology, CPT Pharmacometrics & Systems Pharmacology and Clinical Pharmacokinetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.